Diabetic Ulcer Treatment Market Size, Growth and Trends Analysis By Type (Foot Ulcer, Mouth Ulcer), By Treatment (Wound Care Dressings, Wound Care Devices, Active Therapies) and By End-User (Hospitals and clinics, Ambulatory Surgical Centers, Academic and Research Organization) – Forecast to 2030
ID: MRFR/HC/6888-HCR | 111 Pages | Published By Rahul Gotadki on March 2023
Table of Contents
1. REPORT PROLOGUE
2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3. Limitations
3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Primary Research
3.3. Secondary Research
3.4. Market Size Estimation
4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities
5. MARKET FACTOR ANALYSIS
5.1. Porter’s Five Forces Analysis
5.1.1. Bargaining Power of Suppliers
5.1.2. Bargaining Power of Buyers
5.1.3. Threat of New Entrants
5.1.4. Threat of Substitutes
5.1.5. Intensity of Rivalry
5.2. Value Chain Analysis
6. GLOBAL DIABETIC ULCER TREATMENT MARKET, BY TYPE
6.1. Overview
6.2. Foot Ulcer
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.2.1. Neuropathic Ulcers
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.2.2. Neuro-ischemic Ulcers
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.2.3. Ischemic Ulcers
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.3. Mouth Ulcer
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
6.4. Others
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7. GLOBAL DIABETIC ULCER TREATMENT MARKET, BY TREATMENT
7.1. Wound Care Dressings
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.1.1. Hydrogels
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.1.2. Foams
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
7.1.3. Alginates
Market Estimates & Forecast, by Country, 2020-2027
Market Estimates & Forecast, by Region, 2020-2027
7.1.4. Others
Market Estimates & Forecast, by Country, 2020-2027
Market Estimates & Forecast, by Region, 2020-2027
7.2. Wound Care Devices
Market Estimates & Forecast, by Country, 2020-2027
Market Estimates & Forecast, by Region, 2020-2027
7.2.1. Ultrasound Therapy
Market Estimates & Forecast, by Country, 2020-2027
Market Estimates & Forecast, by Region, 2020-2027
7.2.2. Negative Pressure Wound Therapy device (NPWT)
Market Estimates & Forecast, by Country, 2020-2027
Market Estimates & Forecast, by Region, 2020-2027
7.2.3. Hyperbaric Oxygen Therapy (HBOT)
Market Estimates & Forecast, by Country, 2020-2027
Market Estimates & Forecast, by Region, 2020-2027
7.3. Active Therapies
Market Estimates & Forecast, by Country, 2020-2027
Market Estimates & Forecast, by Region, 2020-2027
7.3.1. Skin grafts and substitutes
Market Estimates & Forecast, by Country, 2020-2027
Market Estimates & Forecast, by Region, 2020-2027
7.3.2. Topical agents
Market Estimates & Forecast, by Country, 2020-2027
Market Estimates & Forecast, by Region, 2020-2027
8. GLOBAL DIABETIC ULCER TREATMENT MARKET, BY END USER
8.1. Overview
8.2. Hospitals and Clinics
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.3. Ambulatory Surgical Centers
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
8.4. Academic and Research Organization
Market Estimates & Forecast, by Region, 2020-2027
Market Estimates & Forecast, by Country, 2020-2027
9. GLOBAL DIABETIC ULCER TREATMENT MARKET, BY REGION
9.1. Overview
9.2. Americas
9.2.1. North America
9.2.1.1. US
9.2.1.2. Canada
9.2.2. Latin America
9.3. Europe
9.3.1. Western Europe
9.3.1.1. Germany
9.3.1.2. France
9.3.1.3. Italy
9.3.1.4. Spain
9.3.1.5. UK
9.3.1.6. Rest of Western Europe
9.3.2. Eastern Europe
9.4. Asia-Pacific
9.4.1. Japan
9.4.2. China
9.4.3. India
9.4.4. Australia
9.4.5. South Korea
9.4.6. Rest of Asia-Pacific
9.5. Middle East & Africa
9.5.1. Middle East
9.5.2. Africa
10. COMPANY LANDSCAPE
10.1.1. Overview
10.1.2. Competitive Analysis
11. COMPANY PROFILES
11.1. Smith & Nephew
11.1.1. Company Overview
11.1.2. Type Overview
11.1.3. Financial Overview
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Integra LifeSciences Corporation
11.2.1. Company Overview
11.2.2. Type Overview
11.2.3. Financial Overview
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. SANUWAVE Health, Inc.
11.3.1. Company Overview
11.3.2. Type Overview
11.3.3. Financial Overview
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Cardinal Health
11.4.1. Company Overview
11.4.2. Type Overview
11.4.3. Financial Overview
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. 3M
11.5.1. Company Overview
11.5.2. Type Overview
11.5.3. Financial Overview
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. B. Braun Melsungen AG
11.6.1. Company Overview
11.6.2. Type Overview
11.6.3. Financial Overview
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. ACELITY L.P. INC.
11.7.1. Company Overview
11.7.2. Type Overview
11.7.3. Financial Overview
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. ConvaTec Group PLC
11.8.1. Company Overview
11.8.2. Type Overview
11.8.3. Financial Overview
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Organogenesis Inc.
11.9.1. Company Overview
11.9.2. Type Overview
11.9.3. Financial Overview
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies
11.10. Mölnlycke Health Care AB
11.10.1. Company Overview
11.10.2. Type Overview
11.10.3. Financial Overview
11.10.4. Key Developments
11.10.5. SWOT Analysis
11.10.6. Key Strategies
11.11. Essity Aktiebolag
11.11.1. Company Overview
11.11.2. Type Overview
11.11.3. Financial Overview
11.11.4. Key Developments
11.11.5. SWOT Analysis
11.11.6. Key Strategies
11.12. Others
12. APPENDIX
12.1. References
12.2. Related Reports
LIST OF TABLES
TABLE 1 GLOBAL DIABETIC ULCER TREATMENT MARKET SYNOPSIS, 2020-2027
TABLE 2 GLOBAL DIABETIC ULCER TREATMENT MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)
TABLE 3 GLOBAL DIABETIC ULCER TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 4 GLOBAL DIABETIC ULCER TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION)
TABLE 5 GLOBAL DIABETIC ULCER TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 6 GLOBAL DIABETIC ULCER TREATMENT MARKET, BY REGION, 2020-2027 (USD MILLION)
TABLE 7 NORTH AMERICA: DIABETIC ULCER TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 8 NORTH AMERICA: DIABETIC ULCER TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION)
TABLE 9 NORTH AMERICA: DIABETIC ULCER TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 10 US: DIABETIC ULCER TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 11 US: DIABETIC ULCER TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION)
TABLE 12 US: DIABETIC ULCER TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 13 CANADA: DIABETIC ULCER TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 14 CANADA: DIABETIC ULCER TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION)
TABLE 15 CANADA: DIABETIC ULCER TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 16 LATIN AMERICA: DIABETIC ULCER TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 17 LATIN AMERICA: DIABETIC ULCER TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION)
TABLE 18 LATIN AMERICA: DIABETIC ULCER TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 19 EUROPE: DIABETIC ULCER TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 20 EUROPE: DIABETIC ULCER TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION)
TABLE 21 EUROPE: DIABETIC ULCER TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 22 WESTERN EUROPE: DIABETIC ULCER TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 23 WESTERN EUROPE: DIABETIC ULCER TREATMENT MARKET, BY TREATMENTT, 2020-2027 (USD MILLION)
TABLE 24 WESTERN EUROPE: DIABETIC ULCER TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 25 EASTERN EUROPE: DIABETIC ULCER TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 26 EASTERN EUROPE: DIABETIC ULCER TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION)
TABLE 27 EASTERN EUROPE: DIABETIC ULCER TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 28 ASIA-PACIFIC: DIABETIC ULCER TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 29 ASIA-PACIFIC: DIABETIC ULCER TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION)
TABLE 30 ASIA-PACIFIC: DIABETIC ULCER TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
TABLE 31 MIDDLE EAST & AFRICA: DIABETIC ULCER TREATMENT MARKET, BY TYPE, 2020-2027 (USD MILLION)
TABLE 32 MIDDLE EAST & AFRICA: DIABETIC ULCER TREATMENT MARKET, BY TREATMENT, 2020-2027 (USD MILLION)
TABLE 33 MIDDLE EAST & AFRICA: DIABETIC ULCER TREATMENT MARKET, BY END USER, 2020-2027 (USD MILLION)
LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL DIABETIC ULCER TREATMENT MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL DIABETIC ULCER TREATMENT MARKET
FIGURE 4 GLOBAL DIABETIC ULCER TREATMENT MARKET SHARE, BY TYPE, 2020(%)
FIGURE 5 GLOBAL DIABETIC ULCER TREATMENT MARKET SHARE, BY TREATMENT, 2020(%)
FIGURE 6 GLOBAL DIABETIC ULCER TREATMENT MARKET SHARE, BY END USER, 2020(%)
FIGURE 7 GLOBAL DIABETIC ULCER TREATMENT MARKET SHARE, BY REGION, 2020(%)
FIGURE 7 AMERICAS: DIABETIC ULCER TREATMENT MARKET SHARE BY REGION, 2020(%)
FIGURE 8 NORTH AMERICA: DIABETIC ULCER TREATMENT MARKET SHARE, BY COUNTRY, 2020(%)
FIGURE 9 EUROPE: DIABETIC ULCER TREATMENT MARKET SHARE, BY REGION, 2020(%)
FIGURE 10 WESTERN EUROPE: DIABETIC ULCER TREATMENT MARKET SHARE, BY COUNTRY, 2020(%)
FIGURE 11 ASIA-PACIFIC: DIABETIC ULCER TREATMENT MARKET SHARE, BY COUNTRY, 2020(%)
FIGURE 12 MIDDLE EAST & AFRICA: DIABETIC ULCER TREATMENT MARKET SHARE, BY COUNTRY, 2020(%)
FIGURE 13 GLOBAL DIABETIC ULCER TREATMENT MARKET: COMPANY SHARE ANALYSIS, 2020(%)
FIGURE 14 SMITH & NEPHEW: KEY FINANCIALS
FIGURE 15 SMITH & NEPHEW: SEGMENTAL REVENUE
FIGURE 16 SMITH & NEPHEW: REGIONAL REVENUE
FIGURE 17 INTEGRA LIFESCIENCES CORPORATION: KEY FINANCIALS
FIGURE 18 INTEGRA LIFESCIENCES CORPORATION: SEGMENTAL REVENUE
FIGURE 19 INTEGRA LIFESCIENCES CORPORATION: REGIONAL REVENUE
FIGURE 20 SANUWAVE HEALTH, INC.: KEY FINANCIALS
FIGURE 21 SANUWAVE HEALTH, INC.: SEGMENTAL REVENUE
FIGURE 22 SANUWAVE HEALTH, INC.: REGIONAL REVENUE
FIGURE 23 CARDINAL HEALTH: KEY FINANCIALS
FIGURE 24 CARDINAL HEALTH: SEGMENTAL REVENUE
FIGURE 25 CARDINAL HEALTH: REGIONAL REVENUE
FIGURE 26 3M: KEY FINANCIALS
FIGURE 27 3M: SEGMENTAL REVENUE
FIGURE 28 3M: REGIONAL REVENUE
FIGURE 29 B. BRAUN MELSUNGEN AG: KEY FINANCIALS
FIGURE 30 B. BRAUN MELSUNGEN AG: SEGMENTAL REVENUE
FIGURE 31 B. BRAUN MELSUNGEN AG: REGIONAL REVENUE
FIGURE 32 ACELITY L.P. INC.: KEY FINANCIALS
FIGURE 33 ACELITY L.P. INC.: SEGMENTAL REVENUE
FIGURE 34 ACELITY L.P. INC.: REGIONAL REVENUE
FIGURE 35 CONVATEC GROUP PLC: KEY FINANCIALS
FIGURE 36 CONVATEC GROUP PLC: SEGMENTAL REVENUE
FIGURE 37 CONVATEC GROUP PLC: REGIONAL REVENUE
FIGURE 38 ORGANOGENESIS INC.: KEY FINANCIALS
FIGURE 39 ORGANOGENESIS INC.: SEGMENTAL REVENUE
FIGURE 40 ORGANOGENESIS INC.: REGIONAL REVENUE
FIGURE 41 MĂ–LNLYCKE HEALTH CARE AB: KEY FINANCIALS
FIGURE 42 MĂ–LNLYCKE HEALTH CARE AB: SEGMENTAL REVENUE
FIGURE 43 MĂ–LNLYCKE HEALTH CARE AB: REGIONAL REVENUE
FIGURE 44 ESSITY AKTIEBOLAG: KEY FINANCIALS
FIGURE 45 ESSITY AKTIEBOLAG: SEGMENTAL REVENUE
FIGURE 46 ESSITY AKTIEBOLAG: REGIONAL REVENUE
